Abbott Receives FDA Clearance for New CELL-DYN® Emerald™ Hematology Instrument - Hospital Management
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Abbott Receives FDA Clearance for New CELL-DYN® Emerald™ Hematology Instrument

Abbott has announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its new, compact hematology instrument, CELL-DYN Emerald™. Abbott’s CELL-DYN Emerald will expand the company’s hematology platform by offering a high performance, affordable solution for small to mid-sized clinical laboratories.

As small to mid-sized hospital laboratories and clinics continue to seek greater efficiency and productivity under tighter space limitations, Emerald’s small size, touch screen software and reliability offer an easy-to-use, compact table/bench top instrument for performing complete blood counts (CBCs), a test routinely ordered by doctors to assess a patient’s overall health and to screen for a variety of disorders such as anemia and infection.

This new hematology system has many automation features designed to save laboratories’ time, allowing them to improve productivity and reduce costs. Time-saving features of Abbott’s CELL-DYN Emerald include:

  • A full touch-screen monitor to simplify operation
  • One-button startup
  • Low reagent consumption
  • Automatic cleaning and shutdown features
  • Barcode labelled reagents

A key facet of CELL-DYN Emerald is its compact size — weighing just 9kg (< 20lbs) — as well as its intuitive software interface that allows for easy navigation and quick results. With Abbott’s Emerald, CBC results are completed in 60 seconds and reported in an easy-to-read format with histograms representing white blood cells, red blood cells and platelets.

“As hospitals and clinics try to do more, faster and in less space, Abbott’s CELL-DYN Emerald offers a compact, fast, reliable analyser to support the hematology testing needs of many small to medium-sized hospital laboratories and clinics,” said Mike Warmuth, senior vice president of diagnostics at Abbott.


Abbott’s CELL-DYN Emerald joins the company’s full line of automated hematology instruments, including CELL-DYN Sapphire®, CELL-DYN Ruby®, CELL-DYN® 3700, CELL-DYN 3200 and CELL-DYN 1800.

Abbott’s CELL-DYN instruments are well known for their efficiency and ability to provide fast access to patient results. Instruments range from larger analysers that process a high number of patient samples to smaller instruments designed for medium and small-volume facilities.

Besides supplying standard CBC results, some instruments have additional features to aid in the evaluation of more complex disease states or infections including cancer, HIV and a variety of anemias.

More About This Company